COVID-19 Testing Falls Short in Long-Term Care Facilities

Only seven states — Connecticut, Maryland, Louisiana, New Hampshire, New Mexico and New York — have ongoing, required testing of residents, staff or both.

Only seven states — Connecticut, Maryland, Louisiana, New Hampshire, New Mexico and New York — have ongoing, required testing of residents, staff or both. Shutterstock

 

Connecting state and local government leaders

Only seven states require regular testing of residents or staff.

This story originally appeared on Stateline.

Residents and staff at long-term care facilities make up nearly 45% of U.S. coronavirus-related deaths. And yet testing — widely considered to be the most important element of stopping the spread of the virus — falls far short of what experts say is needed.

Only seven states — Connecticut, Maryland, Louisiana, New Hampshire, New Mexico and New York — have ongoing, required testing of residents, staff or both.

“What we’ve done in testing in nursing homes and assisted living is a total disaster,” said Brian Lee, director of Families for Better Care, a nursing home advocacy group, and a former long-term care ombudsman in Florida. 

“No one is getting it right. No one. Not a single state. Our nation gets a failing grade in testing in nursing homes.”

In May, the Centers for Medicare and Medicaid Services recommended that long-term care facilities test staff and residents weekly but largely left states on their own to carry it out. In 32 states, at least one round of testing of all long-term care residents and staff has been mandated. In four others, only staff testing has been required.

But a negative test result is useful only for a few days, and many infected people are asymptomatic, so testing should be repeated to get a true sense of the virus’ spread, experts say. Facilities also face delays in getting results back, which further hampers efforts to protect the vulnerable population.

“We knew early on, before the virus even came to this country, that people over 80 with pre-existing conditions were most susceptible,” said Dr. David Gifford, chief medical officer of the American Health Care Association/National Center for Assisted Living. The Washington, D.C.-based group of affiliated state organizations represents more than 14,000 long-term care facilities.

“That’s who we take care of,” he said. “We’ve been asking for testing.”

Delayed Results

As a new surge of cases afflicts the country, leaders of long-term care facilities worry it will hurt their residents.

“Academic research shows with an increase in community spread you see potential for spread into a facility,” said Kevin Warren, president and CEO of the Texas Health Care Association.

In Texas, residents have been ordered to stay in their facilities without visitors for 18 weeks and counting, Warren said. But staff have families to care for and errands to run, and community spread puts them at greater risk of infection.

On top of that, the American Laboratory Association recently said member labs reported delayed turnaround times because of rising demand for tests in the South, Southwest and West.

Those delays carry over into long-term care. Of roughly 1,400 American Health Care Association and National Center for Assisted Living members surveyed at the end of June, more than half reported problems with lab processing of tests. Over 60% said results are taking up to four days, and nearly a quarter said results take five days or longer.

“Our concern is that unless you have widespread availability of testing with rapid results it is very, very hard to begin to talk about how to control this virus,” said the group’s Gifford.

He and other advocates criticized the lack of federal oversight, particularly on the supply chain for testing materials.

States continue to compete with one another, and now must compete with others ramping up testing such as companies, professional sports teams and universities.

“Not only do we need testing of cases, but the whole country is trying to open up again,” said Dr. Rebecca Wurtz, an infectious disease physician and associate professor at the University of Minnesota.

“We don’t have the capacity,” Wurtz said. “We can’t seem to surge the capacity where there’s a surge in cases.”

State-by-State Approach

Even in states that have done baseline testing, there have been challenges.

Mark McKenzie, CEO of Focused Post Acute Care Partners, which runs 31 long-term care facilities across Texas, said the statewide baseline testing had problems. At some facilities, results started taking 16 to 21 days, and tests from four facilities had to be thrown out after a Houston lab had an abnormal number of false positives.

So the company started a contract with a private lab to test the roughly 2,000 residents and 2,200 staff regularly. “We can control the timing,” McKenzie said. “Currently it’s at our cost. It isn’t the most economical way to do it.”

He said he hasn’t seen a bill yet but estimates the cost will be around $300,000 a week. His company has received stimulus money, but he expects to run through it quickly.

“We have no choice,” he said of the testing. “Right now, so we can get a handle and stay as even or somewhat ahead of the process, we are committed to doing that.”

In Arizona, the state health department partnered with Sonora Quest Laboratories to do a baseline test of all residents and staff of long-term care facilities by early June. Staff who tested negative took an antibody test.

According to state health department data, individuals 65 and older account for 11% of cases and 73% of deaths statewide. The state is one of nine that have not shared data on deaths at long-term care facilities, according to the Kaiser Family Foundation.

David Voepel, director of the Arizona Health Care Association, a membership group of long-term care facilities, said the state-funded testing gave a good baseline but the state needs a plan for moving forward. 

“CMS recommends that you do weekly testing of staff,” he said, referring to the Centers for Medicare and Medicaid Services. "We don’t have the ability. A lot of facilities don't have that ability because that’s a lot of money going out.”

In the initial Arizona testing round, a COVID-19 test and an antibody test cost roughly $150 a person, or close to $4 million for about 27,000 residents and staff, Voepel said.

“We’re wondering, is the state going to pay for it? Does the state have a plan for us to do this?” Voepel said. The state’s health department did not respond to a request for information about plans for more long-term care testing.

A few states have focused their efforts on testing staff, a move some experts say might be even more important than testing residents since, in most places, visits have been off-limits for months.

“Staff is going in and out. They’re going home, going to the grocery store. They could get infected tomorrow,” said Toby Edelman, a senior policy attorney with the Center for Medicare Advocacy. “It’s not ‘you get tested once and you’re done.’ 

“If we’re not testing them,” she added, “that’s a serious problem.”

Florida finished testing all residents and staff in mid-June. Shortly thereafter, Republican Gov. Ron DeSantis ordered continued testing of staff every two weeks. 

“I think testing is really critical. It helps our facilities with making clinical decisions,” said Kristen Knapp, spokesperson for the Florida Health Care Association. “This virus presents itself in people with no signs or symptoms.” 

The state has said results will come back in 48 hours, and Knapp said she’s hopeful that will be the case. The first testing round ended July 10. Florida’s health department did not respond to a request for comment on the results.

And more testing will allow facilities to have visitors again, she said.

Rapid Testing

Some experts and advocates say the solution is rapid testing. 

Of the 173 tests approved by the Food and Drug Administration, six are considered rapid tests, meaning they return results while a patient waits rather than being sent to a separate location for laboratory processing, according to agency spokeswoman Nicole Mueller.

However, the FDA says rapid tests have a higher chance of missing an active infection, and providers may order the slower type of test to confirm a negative result.

“The sad thing is, we have the technology,” said Lee of Families for Better Care. “We have the solution to achieve robust testing in nursing homes, but for some reason we aren’t doing it.”

Texas Gov. Greg Abbott, a Republican, recently said the state is working with Omnicare, a CVS Health company, to provide on-site, same-day testing and results for facility staff and residents.

“[Testing] is critical given the nature of the virus and what happens with the elderly,” said Warren of the Texas Health Care Association. “It’s critical that long-term care is a priority when it comes to testing.”

In almost every state that has done baseline testing, the state has paid for it. But not everyone agrees on where the money should come from for more tests.

Abbott also recently announced that long-term care facilities could apply for grants for infection control from a pool of $9 million from civil penalties paid by Medicare- or Medicaid-certified nursing facilities to the Centers for Medicare and Medicaid Services. A portion of this money is returned to the state where the fine was imposed, and can be used to benefit nursing-home residents.

Richard Mollot, executive director of New York City-based Long Term Care Community Coalition, said long-term care providers have a responsibility to provide a safe environment for residents.

“It’s an ongoing disaster across the country. People are in solitary confinement,” he said. “It’s completely outrageous that we’ve been in this situation for four months. It should be completely unacceptable.”

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.